Company intelligence / Profile preview

Iberma

Had Soualem (30 km from Casablanca), Moroccoiberma.com ↗

Ownership: Private
Employees: ~250
Development stage: Commercial

Overview

Iberma is a leading domestic pharmaceutical manufacturer in Morocco with a strong presence in urology, gastroenterology, and psychiatry. The company manufactures and distributes a range of medications and serves as a contract manufacturer for multinational pharmaceutical companies.

Therapeutic areas: Men's HealthOtherPsychiatryGastroenterologyWomen's Health
Modalities: Small molecules
Industry: Biotech

Drug pipeline

1 asset

mycophenolate mofetil

Commercial

Indications: Transplant rejection

Partnerships

Joint venture with Italfarmaco (Italian pharma group)

Beyond the preview

Go deeper on Iberma.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Iberma.

Explore the full profile